Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients.
Saved in:
| Title: | Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. |
|---|---|
| Authors: | Nili M; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. mona.nili@boehringer-ingelheim.com., Epstein AJ; Medicus Economics, LLC, Milton, MA, USA., Nunag D; Medicus Economics, LLC, Milton, MA, USA., Olson A; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA., Borah B; Mayo Clinic, Rochester, MN, USA. |
| Source: | BMC pulmonary medicine [BMC Pulm Med] 2023 Jun 27; Vol. 23 (1), pp. 230. Date of Electronic Publication: 2023 Jun 27. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 100968563 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2466 (Electronic) Linking ISSN: 14712466 NLM ISO Abbreviation: BMC Pulm Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37370093 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nili+M%22">Nili M</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA. mona.nili@boehringer-ingelheim.com.<br /><searchLink fieldCode="AU" term="%22Epstein+AJ%22">Epstein AJ</searchLink>; Medicus Economics, LLC, Milton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Nunag+D%22">Nunag D</searchLink>; Medicus Economics, LLC, Milton, MA, USA.<br /><searchLink fieldCode="AU" term="%22Olson+A%22">Olson A</searchLink>; Boehringer Ingelheim Pharmaceuticals, Inc, Ridgefield, CT, USA.<br /><searchLink fieldCode="AU" term="%22Borah+B%22">Borah B</searchLink>; Mayo Clinic, Rochester, MN, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100968563%22">BMC pulmonary medicine</searchLink> [BMC Pulm Med] 2023 Jun 27; Vol. 23 (1), pp. 230. <i>Date of Electronic Publication: </i>2023 Jun 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BioMed+Central%22">BioMed Central </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100968563 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1471-2466 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214712466%22">14712466 </searchLink><i>NLM ISO Abbreviation: </i>BMC Pulm Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37370093 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12890-023-02496-3 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 230 Titles: – TitleFull: Using group based trajectory modeling for assessing medication adherence to nintedanib among idiopathic pulmonary fibrosis patients. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nili M – PersonEntity: Name: NameFull: Epstein AJ – PersonEntity: Name: NameFull: Nunag D – PersonEntity: Name: NameFull: Olson A – PersonEntity: Name: NameFull: Borah B IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 06 Text: 2023 Jun 27 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 1471-2466 Numbering: – Type: volume Value: 23 – Type: issue Value: 1 Titles: – TitleFull: BMC pulmonary medicine Type: main |
| ResultId | 1 |
